When I was in the CEP-1347 clinical trial, I was in an email group of about 12 others in the trial. We shared our experiences, our side effects, visits to study centers, doctors, and overall how well we were doing etc etc.

Several of my correspondents were doing VERY well - their symptoms hadn't worsened - and they hadn't had to start on pd meds. I admit that I envied them - and I hoped when the trial ended I would get the GOOD dose - the dose they were on.

you can see where this is heading...

When the trial was unblinded, it turned out THEY had been getting the placebo. And I had gotten the lowest dose - the group that did the worst (go figure).